REPRESENTATIONS AND WARRANTIES 3. Section 3.1 Representations and Warranties of the Originator 3 Section 3.2 Representations and Warranties of the Depositor 5
REPRESENTATIONS AND WARRANTIES 3. Section 2.1. Representations and Warranties of the City 3
REPRESENTATIONS AND WARRANTIES 3. Section 2.1 Representations and Warranties of the Company. 3 Section 2.2 Representations and Warranties of the Purchasers. 14
REPRESENTATIONS AND WARRANTIES 3. 1 Each of Institution and Investigator represents and warrants that it/he/she has the legal authority to enter into this Agreement and that the terms of this Agreement are not in conflict with any other agreements to which it/he/she is legally bound. Neither Institution nor Investigator will enter into any agreement or engage in any activities that would materially impair its or his/her ability to complete the Trial in accordance with this Agreement and the Protocol. 3.2 Each of Institution and Investigator represents and warrants that the Investigator is fully qualified as a medical practitioner under applicable laws and regulations and is fit to perform his/her obligations under this Agreement. Each of Institution and Investigator represents and warrants that it/he/she will not, in the course of performing the Trial, use in any capacity the services of any person or entity who has been debarred, disqualified as an investigator, or restricted by any national or international governmental or regulatory authority. Each of Verze 4 Video Capture soupravu zahrnující Lenovo L440 model laptop nebo ekvivalent (xxxx xxx „Vybavení”) na náklady společnost Gilead. Pokud nebude ze strany společnosti Gilead písemně odsouhlaseno jinak, Vybavení bude použito pouze Zkoušejícím a Zaměstnanci zapojenými do výkonu klinického hodnocení, a to pouze za účelem výkonu Klinického hodnocení. Vybavení je a bude výhradním vlastnictvím společnosti Gilead. Vybavení bude použito pouze způsobem zamýšleným a definovaným v písemných pokynech výrobce a/nebo společnosti Gilead. Instituce vynaloží přiměřené úsilí při nakládání s a za účelem bezpečného uskladnění Vybavení. Instituce a Zkoušející bude na náklady společnosti Gilead udržovat vybavení v dobrém provozuschopném stavu. Instituce a Zkoušející neprodleně upozorní společnost Gilead jakmile si bude vědomo nezbytnosti opravy či údržby Vybavení. Po dokončení Klinického hodnocení nebo na žádost společnosti Gilead, Instituce a Zkoušející, pokud nebude sjednáno jinak, vrátí společnosti Gilead, a to na její náklady, Vybavení a veškeré související cvičební materiály a dokumentaci. 3. PROHLÁŠENÍ A ZÁRUKY 3.1 Instituce a Zkoušející tímto prohlašuje a zaručuje, že má zákonné právo uzavřít tuto Smlouvu a že smluvní podmínky této Smlouvy nejsou v konfliktu s žádnou jinou smlouvou, jíž je zákonně vázána. Instituce ani Zkoušející neuzavře žádnou jinou smlouvu nebo se nezaváže k jiným činnostem, které by podstatným způsobem bránily její schopnosti doko...
REPRESENTATIONS AND WARRANTIES 3. 1 The Sellers, jointly and severally, represent and warrant to SCHC the following: (a)
REPRESENTATIONS AND WARRANTIES 3. Section 2.1 Representations and Warranties of the Company 3 Section 2.2 Representations and Warranties of the Purchasers 15 ARTICLE III COVENANTS 17 Section 3.1 Securities Compliance 17 Section 3.2 Registration and Listing 17 Section 3.3 Inspection Rights 18 Section 3.4 Compliance with Laws 18 Section 3.5 Keeping of Records and Books of Account 18 Section 3.6 Reporting Requirements 18 Section 3.7 Other Agreements 18 Section 3.8 Use of Proceeds 18 Section 3.9 Reporting Status 19 Section 3.10 Disclosure of Transaction 19 Section 3.11 Disclosure of Material Information 19 Section 3.12 Pledge of Securities 19 Section 3.13 Amendments 19 Section 3.14 Distributions 19 Section 3.15 Reservation of Shares 20 Section 3.16 [Intentionally Omitted] 20 Section 3.17 [Intentionally Omitted] 20 Section 3.18 Form SB-2 Eligibility 20 Section 3.19 [Intentionally Omitted] 20 Section 3.20 Subsequent Financings 20 Section 3.21 [Intentionally Omitted] 21 Section 3.22 Additional Affirmative Covenants 21 Section 3.23 Additional Negative Covenants 23 ARTICLE IV CONDITIONS 26 Section 4.1 Conditions Precedent to the Obligation of the Company to Close and to Sell the Securities 26 Section 4.2 Conditions Precedent to the Obligation of the Purchasers to Close and to Purchase the Securities 27 ARTICLE V CERTIFICATE LEGEND 29 Section 5.1 Legend 29 Section 5.2 Liquidated Damages 30 Section 5.3 Sales by Purchasers 30 ARTICLE VI INDEMNIFICATION 30 Section 6.1 Company Indemnity 30 Section 6.2 Indemnification Procedure 31 ARTICLE VII MISCELLANEOUS 31 Section 7.1 Fees and Expenses 31 Section 7.2 Specific Performance; Consent to Jurisdiction; Venue 32 Section 7.3 Entire Agreement; Amendment 32 Section 7.4 Notices 32 Section 7.5 Waivers 33 Section 7.6 Headings 33 Section 7.7 Successors and Assigns 33 Section 7.8 No Third Party Beneficiaries 33 Section 7.9 Governing Law 33 Section 7.10 Survival 33 Section 7.11 Counterparts 33 Section 7.12 [Intentionally Omitted] 33 Section 7.13 Severability 34 Section 7.14 Further Assurances 34 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT dated as of January 15, 2008 (this “Agreement”) by and among Ambient Corporation, a Delaware corporation (the “Company”), Vicis Capital Master Fund (“Vicis”) and each of the other purchasers of the secured convertible promissory notes of the Company whose names are set forth on Exhibit A attached hereto (each a “Purchaser” and collectively with Vicis, the “Purchasers”).
REPRESENTATIONS AND WARRANTIES 3. 1 Each Party represents and warrants that the representations and warranties it gives in clause 21 of the LTA are true and correct as at the date of this Amendment Agreement with reference to the facts and circumstances existing at such date, in relation to both this Amendment Agreement and the LTA as amended by this Amendment Agreement. 3.2 Each Party further represents and warrants that this Amendment Agreement constitutes its legal, valid, binding and enforceable obligations in accordance with its terms. 4 MISCELLANEOUS 4.1 Continuation of LTA Save as amended by this Amendment Agreement, the provisions of the LTA shall continue in full force and effect and each of the LTA and this Amendment Agreement shall be read and construed as one instrument. 4.2
REPRESENTATIONS AND WARRANTIES 3. SECTION 2.1. Rockpoint Representations and Warranties 3 SECTION 2.2. Representations and Warranties of VRLP, the General Partner 11 SECTION 2.3. Survival; Limitations 12
REPRESENTATIONS AND WARRANTIES 3. 1 The Company represents and warrants that it is an insurance company duly organized and in good standing under the Laws of the State of Illinois, with full power, authority and legal right to execute, deliver and perform its duties and comply with its obligations under this Agreement and has established each Account as a separate account under such law and the Accounts comply in all material respects with all applicable federal and state laws and regulations. 3.2 The Company represents and warrants that it has registered or, prior to any issuance or sale of the Contracts, will register each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a separate account for the Contracts. The Company further represents and warrants that the Contracts will be registered under the 1933 Act prior to any issuance or sale of the Contracts; the Contracts will be issued in compliance in all material respects with all applicable federal and state laws. 3.3 The Company represents and warrants that the Contracts are currently and at the time of issuance will be treated as annuity contracts or life insurance policies, whichever is appropriate, under applicable provisions of the Internal Revenue Code of 1986, as amended (“Code”). The Company shall make every effort to maintain such treatment and shall notify the Fund and the Underwriter immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future. 3.4 The Fund represents and warrants that it is duly organized and validly existing under the laws of the State of Maryland. 3.5 The Fund represents and warrants that the Fund Shares offered and sold pursuant to this Agreement will be registered under the 1933 Act and the Fund is registered under the 1000 Xxx. The Fund shall amend its registration statement under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its Shares. If the Fund determines that notice filings are appropriate, the Fund shall use its best efforts to make such notice filings in accordance with the laws of such jurisdictions reasonably requested by the Company. 3.6 The Fund has adopted a Distribution Plan (the “Plan”) with regard to the Class II and Class III shares of each Portfolio, pursuant to Rule 12b-1 under the 1940 Act. The Plan permits the Underwriter to pay to each Participating Insurance Company that enters into...
REPRESENTATIONS AND WARRANTIES 3. Section 3.1. The Seller Parties’ Representations and Warranties.. 3
